Ciprofloxacin Dosing
For adults with normal renal function, ciprofloxacin should be dosed at 400 mg IV every 8-12 hours or 500-750 mg orally every 12 hours depending on infection severity; for children, use 10 mg/kg IV every 8-12 hours (max 400 mg/dose) or 15 mg/kg orally every 8-12 hours (max 500-750 mg/dose), with mandatory dose adjustments when creatinine clearance falls below 50 mL/min. 1
Adult Dosing
Standard Dosing (Normal Renal Function)
Oral administration:
- Mild to moderate infections: 500 mg every 12 hours
- Severe/complicated infections: 750 mg every 12 hours
- Uncomplicated UTI: 250 mg every 12 hours
- Duration typically 7-14 days (infection-dependent) 1
Intravenous administration:
- Standard dose: 400 mg every 12 hours
- Severe infections: 400 mg every 8 hours 1
For specific infections, the 2025 CDC tularemia guidelines recommend 400 mg IV every 8 hours or 750 mg orally every 12 hours for adults 2. The 2001 anthrax guidelines specify 400 mg IV every 12 hours or 500 mg orally every 12 hours for inhalational anthrax 3.
Renal Dose Adjustments
Critical threshold: Creatinine clearance <50 mL/min requires dose modification 1
| Creatinine Clearance | Recommended Dose |
|---|---|
| >50 mL/min | Standard dosing |
| 30-50 mL/min | 250-500 mg every 12 hours |
| 5-29 mL/min | 250-500 mg every 18 hours |
| Hemodialysis/CAPD | 250-500 mg every 24 hours (after dialysis) |
For severe infections with renal impairment, 750 mg may be given at the intervals above with careful monitoring 1. Research demonstrates that ciprofloxacin AUC doubles and half-life increases 1.7-fold when creatinine clearance drops below 50 mL/min 4. The drug undergoes both renal excretion (primary) and hepatic metabolism, with alternative elimination pathways partially compensating for reduced renal function 1.
Important caveat: The 2002 HIV/CKD guidelines recommend more conservative adjustments, suggesting 250-500 mg every 12 hours for CrCl 30-50 mL/min and every 18 hours for CrCl <30 mL/min 5. A 2021 systematic review found limited high-quality evidence supporting current renal dosing recommendations for most antibiotics, though ciprofloxacin data suggests dose reduction is appropriate 6.
Pediatric Dosing
Standard Dosing
Intravenous:
- Complicated UTI/pyelonephritis: 6-10 mg/kg every 8 hours (max 400 mg/dose)
- Inhalational anthrax: 10 mg/kg every 12 hours (max 400 mg/dose)
- Duration: 10-21 days for UTI, 60 days for anthrax 1
Oral:
- Complicated UTI/pyelonephritis: 10-20 mg/kg every 12 hours (max 750 mg/dose)
- Inhalational anthrax: 15 mg/kg every 12 hours (max 500 mg/dose)
- Cutaneous anthrax: 10-15 mg/kg every 12 hours (not to exceed 1 g/day) 3, 1
The 2011 AAP fluoroquinolone guidelines specify ciprofloxacin 20-40 mg/kg/day divided every 12 hours orally (max 750 mg/dose) or 20-30 mg/kg/day IV divided every 8-12 hours (max 400 mg/dose) 7.
Critical consideration: A 2025 population PK study in critically ill children found standard dosing (10 mg/kg every 12 hours) achieved only 75-80% target attainment for MIC 0.25 mg/L. For non-ventilated critically ill children with normal renal function, 15 mg/kg every 8 hours may be required (though this is off-label), while ventilated patients achieve adequate exposure with standard dosing 8.
Pediatric Renal Adjustments
Pediatric patients with moderate to severe renal insufficiency (CrCl <50 mL/min/1.73m²) were excluded from major trials. No established pediatric renal dosing guidelines exist 1. Extrapolating from adult data, dose reduction or interval prolongation would be prudent when CrCl <50 mL/min/1.73m².
Critical Dosing Principles
Timing and Administration
- Administer at least 2 hours before or 6 hours after antacids containing magnesium/aluminum, sucralfate, calcium, iron, or zinc supplements 1
- Oral ciprofloxacin is rapidly absorbed with 70-80% bioavailability, reaching peak levels in 1-2 hours 3
- IV-to-oral conversion is appropriate when clinically stable: 250 mg PO ≈ 200 mg IV; 500 mg PO ≈ 400 mg IV every 12h; 750 mg PO ≈ 400 mg IV every 8h 1
Pharmacodynamic Optimization
Ciprofloxacin exhibits concentration-dependent killing. The 2017 Surviving Sepsis guidelines recommend optimizing peak concentrations: 600 mg IV every 12 hours or 750 mg orally every 24 hours (assuming preserved renal function) for serious infections 9. Research suggests that prolonging the dosing interval rather than reducing the dose may be preferable in renal failure to maintain peak concentrations above MIC 10.
Special Populations
Obesity: A 2025 systematic review found ciprofloxacin volume of distribution increases with bodyweight but not linearly. Dose adjustment is generally not necessary unless impaired tissue penetration is anticipated, though one study suggested dosing based on adjusted bodyweight (IBW + 45% excess weight) 11.
Elderly: No dose adjustment needed for age alone with normal renal function, but monitor renal function as age-related decline may necessitate adjustment 1. Greater susceptibility to QT prolongation and tendon disorders exists 1.
Common Pitfalls
- Failing to adjust for renal function: Always calculate creatinine clearance; the threshold of 50 mL/min (not 30 mL/min) triggers dose modification
- Exceeding maximum doses in children: Despite weight-based dosing, never exceed 400 mg IV per dose or 750 mg oral per dose 1
- Inadequate dosing in critically ill children: Standard dosing may be insufficient in non-ventilated children with augmented renal clearance 8
- Drug interactions: Divalent/trivalent cations dramatically reduce absorption; maintain proper spacing 1
- Assuming hemodialysis removes drug: Ciprofloxacin is poorly dialyzed; dose after dialysis but don't supplement 5